Literature DB >> 26117622

Percutaneous Coronary Interventions for Chronic Total Occlusions: More Benefit for the Patient or for the Interventionist's Ego?

Alfredo R Galassi1, Marouane Boukhris2, Salvatore Azzarelli3, Francesco Marzà3, Salvatore D Tomasello3.   

Abstract

Chronic total occlusions (CTOs) represent a common lesion subset observed in patients who undergo coronary angiography. During the past decade, the interest of the interventionist community in CTOs has exponentially grown with fast advancement in dedicated equipment and techniques, which has resulted in high rates of procedural success and low rates of complications. Although different observational studies have shown that CTO revascularization was associated with good clinical outcome, its real benefit for patients remains to be determined, particularly in the absence of randomized trials. In addition, compared with non-CTO lesions, the American and European guidelines downgraded percutaneous coronary intervention in the setting of CTOs. In this viewpoint, we try to identify patients who would benefit from CTO recanalization, and discuss the issues that might improve the appropriateness of CTO percutaneous coronary intervention.
Copyright © 2015 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26117622     DOI: 10.1016/j.cjca.2015.03.001

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  2 in total

1.  Predictive scores in chronic total occlusions percutaneous recanalization: only fashionable or really useful?

Authors:  Marouane Boukhris; Kambis Mashayekhi; Zied Ibn Elhadj; Alfredo R Galassi
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

Review 2.  Validation of the newly introduced CASTLE Score for predicting successful CTO recanalization.

Authors:  Jan-Erik Guelker; Yoshihisa Kinoshita; Joachim Weber-Albers; Alexander Bufe; Christian Blockhaus; Kambis Mashayekhi
Journal:  Int J Cardiol Heart Vasc       Date:  2022-01-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.